Related products
La Lettre Emerit – L’évaluation sociétale des nanotechnologies: un tour d’Europe
L’évaluation sociétale des nanotechnologies: un tour d’Europe
Bioethics Caribe
- Abstracts
- Ethics, Equality & Stigma – Some Issues of Relevance to the English-Speaking Caribbean
- The Changing Face of Stigma: Social Taboos and Ethics
- Disclosure of STD infection to sex partners in Louisiana
- Ethics and Inequalities Associated with Caribbean Impacts of Climate Change
- The Ethical Challenge Posed by Stigma to Public Health Promotion Campaigns and the Health- Care Professional Patient Interaction
- Human Rights: A Framework for Confronting Stigma in the Caribbean
- Ethics, Equality and Stigma: a Canadian Perspective
- Ethical dilemmas of critically and terminally ill HIV/AIDS patients in the ICU
NGLS interviews Dr. Astrid Stuckelberger, Chair of the UN NGO Committee on Ageing Geneva and President of the Geneva International Network on Ageing
NGLS interviews Dr. Astrid Stuckelberger, Chair of the UN NGO Committee on
Ageing Geneva and President of the Geneva International Network on Ageing
On the occasion of the eighteenth session of the Human Rights Council and the 20th annual celebration of the UN International Day of Older Persons (1 October), a High- level Panel on Older Women and the Right to Health was held on 26 September in Geneva. The Panel was co-sponsored by the UN NGO Committee on the Status of Women Geneva and a number of other civil society organizations including the Geneva International Network on Ageing; the Women’s UN Report Network (WUNRN); Help Age International; and the International Disability Alliance.
«Man kann viel fürs gute Altern tun»
Unter dem Stichwort «Anti- Aging» werden Therapien angeboten, die das Altern verlangsamen sollen. Andreas Stuck, Berner Professor für Altersmedizin, warnt vor falschen Versprechungen und preist breite Prävention an.
La jeunesse s’achète-t-elle?
La jeunesse s’achète-t-elle?
Du moins, pas encore. Inventée en 1993, la médecine antivieillissement engendre des chiffres d’affaires inversement proportionnels à son efficacité prouvée.